Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -15.08 | N/A |
| PEG Ratio (TTM) | 0.14 | N/A |
| P/S Ratio (TTM) | 0.29 | N/A |
| P/B Ratio (TTM) | 0.35 | N/A |
| P/FCF Ratio (TTM) | 18.37 | N/A |
| Price to 5YR AVG Earnings Ratio | 4.60 | N/A |
| Price to 5YR AVG FCF Ratio | 4.38 | N/A |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.33% | N/A |
| ROE (TTM) | -2.32% | N/A |
| Net Profit Margin (TTM) | -1.99% | N/A |
| ROIC 5YR AVG | 10.44% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -66.17% | 1,222.38% | 706.58% |
| Revenue | 8.27% | 4.02% | 0.37% |
| Net Income | -65.60% | 1,191.17% | 685.76% |
| Cash Flow | 318.84% | 51.30% | 26.37% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.46 | N/A |
| Quick Ratio (TTM) | 0.59 | N/A |
| D/E Ratio (TTM) | 0.21 | N/A |
| Interest Coverage (TTM) | 1.35 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.29 | N/A |
| LTL to 5YR AVG FCF | 2.02 | N/A |
| Shares Outstanding Growth 5YR AVG | -3.17% | N/A |